Medtronic 2013 Annual Report Download - page 13
Download and view the complete annual report
Please find page 13 of the 2013 Medtronic annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.12
21
23 24
22
35
19
31 32
28
34
25 26 27
20
1
2
3
4
5
6
8
9
30
15
11
33
14
16
7
7
38
36
37
39
17
10
18
29
40
13
Cardiac Rhythm
1 Atrial Fibrillation
2 Slow Heart Rates (Bradycardia) ‡
3 Fast Heart Rates (Tachycardia) ‡
4 Heart Failure ‡
5 Asymptomatic, Irregular Heart Rates ‡
Coronary
6 Coronary Artery Disease
7 Treatment-Resistant Hypertension *
Structural Heart
8 Heart Valve Disease
9 Congenital Heart Disease
Endovascular
10 Peripheral Vascular Disease
11 Aortic Aneurysms
Spinal and Orthopedic
12 Cervical Degenerative Disc Disease †
13 Scoliosis †
14 Degenerative Disc Disease †
15 Spinal Fracture †
16 Lumbar Spinal Stenosis †
17 Tibial Fractures †
18 Orthopedic Trauma †
Ear, Nose, and Throat
19 Sinus Diseases †
20 Thyroid Conditions
21 Otologic Disorders †
22 Sleep-Disordered Breathing
23 Pediatric Conditions †
24 Ménière’s Disease
Neurological
25 Parkinson’s Disease †
26 Essential Tremor †
27 Dystonia † **
28 Hydrocephalus †
29 Obsessive-Compulsive Disorder † **
30 Severe Spasticity associated with Multiple Sclerosis,
Cerebral Palsy, Stroke, and Spinal Cord and Brain Injuries
31 Epilepsy † *
32 Brain Tumors and Other Lesions †
33 Chronic Pain
34 Subdural Hematomas
35 Cranial Trauma †
Urological/Urogynecological and Gastroenterological
36 Overactive Bladder and Urinary Retention
37 Nausea and Vomiting associated with Gastroparesis **
38 Fecal Incontinence
Diabetes
39 Diabetes
40 Inpatient Dsyglycemia*
* Not approved for commercial distribution in the U.S.
** The Medtronic therapy for this disorder is available in the U.S. through a
Humanitarian Device Exemption. The effectiveness of the therapy for this
disorder has not been demonstrated.
† In addition to devices that treat these conditions, we offer Image-Guided
Navigation Surgical Systems to help surgeons.
‡ Remote Monitoring available with select cardiac devices for clinicians to follow
patients and their implanted cardiac devices remotely, eliminating the need
for some in-office visits.
Our Therapies
Chronic disease is the leading cause of mortality worldwide and a signicant nancial burden on society.
Our products, therapies, and surgical technologies are used to treat many chronic conditions to help
improve quality of life and advance healthcare.
About Medtronic
Medtronic is the global leader in medical technology, oering an
unprecedented breadth and depth of innovative products, therapies,
and services to fulll our Mission of alleviating pain, restoring health,
and extending life. In the past year, more than 9 million people
worldwide relied on our therapies, which treat many conditions
including cardiac and vascular diseases, diabetes, and
neurological and spinal conditions.
With a global reach that extends to more than
140 countries, we have a deep understanding
of many universal healthcare challenges. We are
using our experience, extensive partnerships,
and the passion of more than 46,000 employees
to help transform healthcare worldwide by
improving outcomes, expanding access,
and enhancing value.
Medtronic is headquartered in
Minneapolis, Minnesota, U.S., and
is publicly traded on the New York
Stock Exchange under the ticker
symbol MDT.
Our Mission
To contribute to human welfare by
application of biomedical engineering
to alleviate pain, restore health, and
extend life.
Pictured on the front: Cheon Young-Mi and
her daughter Jeong Hye-Joo in Jinju City, Korea.
Cheon Young-Mi’s cervical dystonia was treated
with Medtronic Deep Brain Stimulation Therapy.**
We also oer advanced energy electrosurgical
instruments indicated for use in orthopedic, spinal,
thoracic, reconstructive plastic, surgical oncology, ear,
nose, and throat (ENT), and general surgery procedures.
75732me_cover.indd 2 6/28/13 3:48 PM
Our Mission
To contribute to human welfare by application of biomedical engineering
in the research, design, manufacture, and sale of instruments or
appliances that alleviate pain, restore health, and extend life.
Contribuir al bienestar humano mediante la aplicación
de ingeniería biomédica en la investigación, diseño,
fabricación y venta de dispositivos o aparatos que alivian
el dolor, restauran la salud y prolongan la vida.
Contribuer au bien-être de l’homme
en appliquant les principes de
l’ingénierie biomédicale à la recherche,
à la conception, à la fabrication et
à la distribution de matériels ou
d’appareillages qui soulagent la douleur,
rétablissent la santé et prolongent la vie.
Contribuire al benessere umano Einen Beitrag zum Wohle der
applicando l’ingegneria biomedica Menschen zu leisten durch
angewandte biomedizinische
alla ricerca, alla progettazione, Technik zur Rehabilitation,
alla produzione e alla vendita di Lebensverlängerung,
strumenti o apparecchi che eliminano Schmerzlinderung und
il dolore, ridonano la salute e Steigerung der Lebensqualität.
prolungano qualitativamente la vita.
To read the Medtronic Mission in its entirety, go to medtronic.com